NNVC
NNVC
AMEX · Biotechnology

Nanoviricides Inc

$0.88
+0.03 (+3.53%)
As of Feb 8, 2:24 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 9.32M 9.26M 9.19M
Net Income 712.1K 643.5K 610.9K
EPS
Profit Margin 7.6% 7.0% 6.7%
Rev Growth +16.1% +5.9% +8.5%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 9.12M 8.03M 7.99M
Total Equity 7.88M 7.30M 6.95M
D/E Ratio 1.16 1.10 1.15
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 971.8K 983.2K 961.2K
Free Cash Flow 631.5K 606.6K 819.9K